X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (941) 941
Publication (172) 172
Paper (115) 115
Book / eBook (23) 23
Patent (14) 14
Report (8) 8
Conference Proceeding (7) 7
Book Chapter (6) 6
Book Review (4) 4
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (313) 313
index medicus (268) 268
female (215) 215
male (186) 186
adult (141) 141
middle aged (138) 138
physics (132) 132
experiment (131) 131
aged (129) 129
high energy physics - experiment (113) 113
experimental results (111) 111
particle physics (106) 106
physics - high energy physics - experiment (99) 99
cms (98) 98
cern lhc coll (97) 97
oncology (89) 89
high energy physics (88) 88
physics of elementary particles and fields (77) 77
p p: scattering (75) 75
8000 gev-cms (73) 73
p p: colliding beams (71) 71
cancer (65) 65
phenomenology (64) 64
analysis (62) 62
aged, 80 and over (58) 58
adolescent (53) 53
care and treatment (49) 49
risk factors (49) 49
treatment outcome (48) 48
animals (46) 46
diagnosis (44) 44
colliding beams [p p] (42) 42
endocrinology & metabolism (42) 42
scattering [p p] (41) 41
young adult (40) 40
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (38) 38
neurosciences (38) 38
particle physics - experiment (38) 38
research (38) 38
expression (36) 36
italy (36) 36
chemotherapy (35) 35
mutation (35) 35
surgery (34) 34
tumors (34) 34
child (33) 33
immunohistochemistry (33) 33
internal medicine (33) 33
medicine & public health (33) 33
nuclear experiment (33) 33
patients (33) 33
disease (32) 32
pathology (31) 31
physics, particles & fields (31) 31
psychiatry (31) 31
health aspects (30) 30
prognosis (30) 30
prospective studies (29) 29
risk (29) 29
prevalence (28) 28
hematology (27) 27
mice (26) 26
mortality (26) 26
retrospective studies (26) 26
survival (26) 26
therapy (26) 26
background (25) 25
follow-up studies (25) 25
astronomy & astrophysics (24) 24
diabetes (24) 24
immunology (24) 24
time factors (24) 24
children (23) 23
medical research (23) 23
pharmacology & pharmacy (23) 23
clinical neurology (22) 22
genetic aspects (22) 22
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (21) 21
inflammation (21) 21
medicine (21) 21
abridged index medicus (20) 20
apoptosis (20) 20
neoplasm staging (20) 20
breast cancer (19) 19
article (18) 18
child, preschool (18) 18
clinical trials (18) 18
hematology, oncology and palliative medicine (18) 18
italy - epidemiology (18) 18
jet: bottom (18) 18
medicine, experimental (18) 18
metastasis (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
cell line, tumor (17) 17
cohort studies (17) 17
comorbidity (17) 17
data analysis method (17) 17
epidemiology (17) 17
kinematics (17) 17
medicine, research & experimental (17) 17
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (10) 10
UTL at Downsview - May be requested (5) 5
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Art - Library use only (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Media Commons - Audio Visual (1) 1
Music - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Reference (1) 1
Robarts - Storage (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
UofT at Mississauga - 1st Floor (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 6, pp. 812 - 822
Summary Background Previous trials from our group suggested an overall survival benefit with five cycles of adjuvant full-dose epirubicin plus ifosfamide in... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | CRITERIA | THERAPY | RECIST | CLINICAL-TRIAL | HIGH-GRADE | ONCOLOGY | DOSE ADJUVANT CHEMOTHERAPY | EXTREMITIES | TUMOR RESPONSE ASSESSMENT | IFOSFAMIDE | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Epirubicin - administration & dosage | Trabectedin | Sarcoma - therapy | Young Adult | Neurilemmoma - therapy | Dioxoles - administration & dosage | Back | Adult | Neutropenia - chemically induced | Child | Extremities | Soft Tissue Neoplasms - therapy | Dacarbazine - administration & dosage | Thoracic Wall | Sarcoma, Synovial - therapy | Deoxycytidine - administration & dosage | Risk Factors | Docetaxel | Anemia - chemically induced | Etoposide - administration & dosage | Tetrahydroisoquinolines - administration & dosage | Thrombocytopenia - chemically induced | Abdominal Wall | Sarcoma - pathology | Leiomyosarcoma - therapy | Disease-Free Survival | Taxoids - administration & dosage | Ifosfamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Chemotherapy, Adjuvant - methods | Neoadjuvant Therapy - methods | Adolescent | Soft Tissue Neoplasms - pathology | Aged | Deoxycytidine - analogs & derivatives | Liposarcoma, Myxoid - therapy | Care and treatment | Anthracyclines | Sarcoma | Adjuvant treatment | Clinical trials | Product development | Standards | Cancer
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2018, Volume 13, Issue 1, p. e0191820
The maintenance of muscle function into late life protects against various negative health outcomes. The present study was undertaken to evaluate the impact of... 
FALLS | OLDER-ADULTS | MULTIDISCIPLINARY SCIENCES | DISABILITY | SARCOPENIA | LOWER-EXTREMITY FUNCTION | PREVALENCE | LIFE
Journal Article
The Journal of Pathology, ISSN 0022-3417, 02/2016, Volume 238, Issue 3, pp. 389 - 400
Small cell carcinoma of the ovary, hypercalcaemic type (SCCOHT) is a lethal and sometimes familial ovarian tumour of young women and children. We and others... 
trichostatin A | SMARCA2/BRM | SMARCB1/INI1 | SMARCA4/BRG1 | SWI/SNF | small cell carcinoma | HDAC inhibitor | rhabdoid tumour | epigenetic silencing | hypercalcaemic type | DOWN-REGULATION | CYCLE ARREST | BRM EXPRESSION | PATHOLOGY | LUNG-CANCER | CD44 EXPRESSION | CANCER GENOMICS | BRG-1 | HIGH-GRADE | ONCOLOGY | NEUROENDOCRINE CARCINOMA | RHABDOID TUMOR | Immunohistochemistry | Carcinoma, Small Cell - genetics | Humans | Transcription Factors - deficiency | DNA-Binding Proteins - deficiency | DNA-Binding Proteins - metabolism | Ovarian Neoplasms - genetics | SMARCB1 Protein | Cell Transformation, Neoplastic - genetics | Nuclear Proteins - deficiency | Biomarkers, Tumor - metabolism | Female | Nuclear Proteins - genetics | DNA Helicases - genetics | Hypercalcemia - genetics | Chromosomal Proteins, Non-Histone - metabolism | Ovarian Neoplasms - diagnosis | Cell Proliferation - physiology | Adenosine Triphosphatases - metabolism | Nuclear Proteins - metabolism | DNA Helicases - deficiency | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Mutation - genetics | Carcinoma, Small Cell - diagnosis | Chromosomal Proteins, Non-Histone - deficiency | Chromosomal Proteins, Non-Histone - genetics | Transcription Factors - metabolism | DNA Helicases - metabolism | Cell Line, Tumor | Gene Silencing - physiology | Carcinoma | Sarcoma | Adenosine triphosphatase | Ovarian cancer | Cancer | SMARCB1 | SWI | BRG1 | Original Papers | Original Paper | SNF | SMARCA2 | SMARCA4 | INI1 | BRM
Journal Article